SOUTH SAN FRANCISCO, Calif. — April 10, 2024 — Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced that Amber Salzman, Ph.D., chief executive officer, participated in a fireside chat at the Canaccord Genuity – Genetic Medicine for Generalists Fireside Chat today. Institutional … Read more
SOUTH SAN FRANCISCO, Calif. — April 9, 2024 — Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced the acceptance of six abstracts, three oral presentations, and three poster presentations at the upcoming Annual Meeting of the American Society of Gene & Cell … Read more
SOUTH SAN FRANCISCO, Calif. — April 1, 2024 — Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium at 9:40 a.m. PT, Tuesday, April 2, 2024. … Read more